Copper Sulfide-Decorated Gd2O3 Nanorods: A Promising Probe for Magnetic Resonance Imaging and Photothermal Therapy
Source abstract
Abstract
The development of bifunctional nanoplatform-based theranostics has garnered considerable attention in cancer therapy research. In this study, we engineer Gd 2 O 3 @SiO 2 -CuS nanorods as an integrated diagnostic-therapeutic system, simultaneously harnessing photothermal conversion and paramagnetic properties for MRI-assisted photothermal intervention. Hydrothermally synthesized Gd 2 O 3 nanorods demonstrate superior T 1 -weighted contrast performance, achieving a longitudinal relaxivity ( r 1 ) of 4.2 mM –1 ·s –1, which compares favorably with that of commercial contrast agents. Furthermore, the strategically integrated CuS component exhibits remarkable photothermal conversion efficiency (19.6%) and sustained therapeutic stability. These attributes pave the way for achieving the application objective of magnetic resonance imaging-assisted photothermal therapy. Critically, comprehensive biosafety evaluations, including hemocompatibility assays and cytotoxicity profiling, confirm the nanocomposite’s favorable biocompatibility. The findings underscore the substantial potential of Gd 2 O 3 @SiO 2 -CuS nanorods for image-guided photothermal therapy applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry
Capital Normal University
Funding
National Natural Science Foundation of China
References (38)
Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1002/cncr.3534710.1002/cncr.35347 ↗
3. 10.1038/s41568-024-00690-x10.1038/s41568-024-00690-x ↗
4. 10.1016/j.biopha.2023.11507010.1016/j.biopha.2023.115070 ↗
5. 10.1016/j.cej.2022.13714710.1016/j.cej.2022.137147 ↗
6. 10.3390/molecules2801027710.3390/molecules28010277 ↗
7. 10.1039/D1NR05449J10.1039/D1NR05449J ↗
8. 10.1016/j.dyepig.2023.11181210.1016/j.dyepig.2023.111812 ↗
9. 10.1039/D4TC01535E10.1039/D4TC01535E ↗
10. 10.1002/adhm.20230111610.1002/adhm.202301116 ↗
11. 10.1186/s12951-023-02072-110.1186/s12951-023-02072-1 ↗
12. 10.1016/j.canlet.2016.12.02610.1016/j.canlet.2016.12.026 ↗
13. 10.1186/s12951-023-02280-910.1186/s12951-023-02280-9 ↗
14. 10.2147/IJN.S28741510.2147/IJN.S287415 ↗
15. 10.1039/D1NH00291K10.1039/D1NH00291K ↗
16. 10.1016/j.actbio.2018.03.03510.1016/j.actbio.2018.03.035 ↗
17. 10.1016/j.cej.2022.13886410.1016/j.cej.2022.138864 ↗
18. 10.1021/acsami.8b0933010.1021/acsami.8b09330 ↗
19. 10.1021/acs.accounts.7b0029410.1021/acs.accounts.7b00294 ↗
20. 10.1002/smll.20170243110.1002/smll.201702431 ↗
21. 10.1016/j.dyepig.2022.11017410.1016/j.dyepig.2022.110174 ↗
22. 10.1016/j.dyepig.2022.11008010.1016/j.dyepig.2022.110080 ↗
23. 10.3390/nano1313200310.3390/nano13132003 ↗
24. 10.1007/s12274-023-6214-910.1007/s12274-023-6214-9 ↗
25. 10.1016/j.dyepig.2019.03.04810.1016/j.dyepig.2019.03.048 ↗
26. 10.1007/BF0318431610.1007/BF03184316 ↗
27. 10.1007/s00259-022-05830-910.1007/s00259-022-05830-9 ↗
28. 10.1021/acsanm.3c0427210.1021/acsanm.3c04272 ↗
29. 10.1007/s11426-023-1898-410.1007/s11426-023-1898-4 ↗
30. 10.1002/adhm.20200178010.1002/adhm.202001780 ↗
31. 10.1039/C5NR08402D10.1039/C5NR08402D ↗
32. 10.1039/C5TB02619A10.1039/C5TB02619A ↗
33. 10.1039/b925097b10.1039/b925097b ↗
34. 10.1039/D0NR90135K10.1039/D0NR90135K ↗
35. 10.1039/C4TB00919C10.1039/C4TB00919C ↗
36. 10.1016/j.mattod.2015.11.00610.1016/j.mattod.2015.11.006 ↗
37. 10.1039/C2TB00243D10.1039/C2TB00243D ↗
38. 10.1021/acsami.2c0650310.1021/acsami.2c06503 ↗